Curis
CRIS
#10267
Rank
$21.3 M
Marketcap
$0.53
Share price
-2.61%
Change (1 day)
-74.62%
Change (1 year)

P/E ratio for Curis (CRIS)

P/E ratio as of April 2026 (TTM): -0.1449

According to Curis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.14485. At the end of 2024 the company had a P/E ratio of -0.4353.

P/E ratio history for Curis from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-0.4353-69.17%
2023-1.4156.98%
2022-0.8994-90.55%
2021-9.52-22.12%
2020-12.2597.48%
2019-1.75151.46%
2018-0.6970
2016-6.8417.6%
2015-5.82-18.52%
2014-7.14-62.01%
2013-18.89.62%
2012-17.2-56.03%
2011-39.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Pfizer
PFE
20.9-14,508.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
17.9-12,488.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-2.86 1,875.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
15.2-10,614.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-8.08 5,477.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-0.3029 109.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
5.99-4,237.32%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.